According to the press release, the NeuroBlate System combines updated, active MRI visualization and a surgical laser to selectively ablate diseased brain tissue. Monteris Medical’s first generation system has been available in U.S. hospitals since 2010. Regarding its new system, John Schellhorn, President and CEO of Monteris Medical, states that:
Monteris invested significant resources to develop a laser ablation system that is faster and adapts to contemporary clinical workflow. The NeuroBlate System provides neurosurgeons controlled, three-dimensional ablation via a powerful software platform. It supports surgical decision making during brain operations as well as providing post-procedure confirmation of the effects of the thermal therapy.
The press release also indicates that the Cleveland Clinic will soon be adopting Monteris Medical’s second generation NeuroBlate System to treat patients who seek minimally invasive options or are not candidates for traditional surgery.